Prescription drug · ANDA
Tacrolimus NDC 50268-737
Tacrolimus 1 mg/1 · Capsule · Oral · AvPAK
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50268-737-15 | 5026807371550268073715 | 50 BLISTER PACK in 1 BOX (50268-737-15) / 1 CAPSULE in 1 BLISTER PACK (50268-737-11)Marketed from Sep 20, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Tacrolimus
- Generic name (nonproprietary)
- tacrolimus
- Active ingredients
- Tacrolimus — 1 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- AvPAKNDC labeler code 50268
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090509
- Marketing start
- Listing expires
- Other FDA classes
- Calcineurin Inhibitors (Mechanism)
- Identifiers
- Product ID 50268-737_5bf16999-e946-d4c5-e063-6394a90aa389SPL ID 5bf16999-e946-d4c5-e063-6394a90aa389
- Pharmacologic class
- Calcineurin Inhibitor Immunosuppressant
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450268073715followed by a unit qualifier and the quantityPackage 50268-0737-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 50268-737
- What is NDC 50268-737?
- 50268-737 is the product NDC for Tacrolimus, Tacrolimus 1 mg/1 capsule, listed with the FDA by AvPAK. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Tacrolimus.
- What is the active ingredient?
- Tacrolimus.
- Who is the labeler?
- AvPAK, NDC labeler code 50268. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Tacrolimus?
- 93 other product NDCs are listed under this name. See all Tacrolimus NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Tacrolimus products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Tacrolimus | Tacrolimus .5 mg/1 | CapsuleOral | AvPAK | 50268-736 | 50268-0736-15 |
| Tacrolimus | Tacrolimus .5 mg/1 | CapsuleOral | Safecor Health LLC | 48433-092 | 48433-0092-20 |
| Tacrolimus | Tacrolimus 1 mg/1 | CapsuleOral | Safecor Health LLC | 48433-093 | 48433-0093-20 |
| Tacrolimus | Tacrolimus 5 mg/1 | CapsuleOral | Safecor Health LLC | 48433-094 | 48433-0094-20 |
| Tacrolimus | Tacrolimus .5 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals NY LLC | 69238-2780 | 69238-2780-03 |
| Tacrolimus | Tacrolimus 1 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals NY LLC | 69238-2781 | 69238-2781-03 |
| Tacrolimus | Tacrolimus 5 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals NY LLC | 69238-2782 | 69238-2782-03 |
| Tacrolimus | Tacrolimus 5 mg/mL | InjectionIntravenous | Nexus Pharmaceuticals, LLC | 14789-135 | 14789-0135-05 |
| Tacrolimus | Tacrolimus .5 mg/1 | CapsuleOral | Stellon Biotech Inc. | 85972-101 | 85972-0101-0185972-0101-30 |
| Tacrolimus | Tacrolimus 1 mg/1 | CapsuleOral | Stellon Biotech Inc. | 85972-102 | 85972-0102-0185972-0102-30 |
Other NDCs under ANDA 090509
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Tacrolimus | Tacrolimus .5 mg/1 | CapsuleOral | Major Pharmaceuticals | 0904-6623 |
| Tacrolimus | Tacrolimus 5 mg/1 | CapsuleOral | Major Pharmaceuticals | 0904-6624 |
| Tacrolimus | Tacrolimus 1 mg/1 | CapsuleOral | Quallent Pharmaceuticals Health LLC | 82009-054 |
| Tacrolimus | Tacrolimus .5 mg/1 | CapsuleOral | American Health Packaging | 68084-449 |
| Tacrolimus | Tacrolimus 1 mg/1 | CapsuleOral | American Health Packaging | 68084-450 |
| Tacrolimus | Tacrolimus 5 mg/1 | CapsuleOral | American Health Packaging | 68084-451 |
| Tacrolimus | Tacrolimus .5 mg/1 | CapsuleOral | Quallent Pharmaceuticals Health LLC | 82009-164 |
| Tacrolimus | Tacrolimus 5 mg/1 | CapsuleOral | Quallent Pharmaceuticals Health LLC | 82009-165 |
| Tacrolimus | Tacrolimus .5 mg/1 | CapsuleOral | AvPAK | 50268-736 |
| Tacrolimus | Tacrolimus 5 mg/1 | CapsuleOral | Dr. Reddy's Laboratories Limited | 55111-527 |
| Tacrolimus | Tacrolimus .5 mg/1 | CapsuleOral | Dr. Reddy's Laboratories Limited | 55111-525 |
| Tacrolimus | Tacrolimus 1 mg/1 | CapsuleOral | Dr. Reddy's Laboratories Limited | 55111-526 |